VIR·92764N102·US·equity·Healthcare - Biotechnology-Activist
VIR (VIR BIOTECHNOLOGY INC) is held by 132 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($161.3M), SB INVESTMENT ADVISERS (UK) LTD ($98.1M), STATE STREET CORP ($64M). Net institutional sentiment: Bullish.
See how VIR's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer